SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-14-002330
Filing Date
2014-07-30
Accepted
2014-07-30 08:04:59
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10q.htm 10-Q 534219
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 13835
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 13978
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 4880
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 4951
  Complete submission text file 0001493152-14-002330.txt   5585533

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE corx-20120930.xml EX-101.INS 787641
7 XBRL SCHEMA FILE corx-20120930.xsd EX-101.SCH 61420
8 XBRL CALCULATION FILE corx-20120930_cal.xml EX-101.CAL 55845
9 XBRL DEFINITION FILE corx-20120930_def.xml EX-101.DEF 222236
10 XBRL LABEL FILE corx-20120930_lab.xml EX-101.LAB 412083
11 XBRL PRESENTATION FILE corx-20120930_pre.xml EX-101.PRE 300451
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 141001292
SIC: 2834 Pharmaceutical Preparations